- Home
- AVIR vs CLBR Comparison
AVIR vs CLBR Comparison
Compare AVIR & CLBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- CLBR
- Stock Information
- Founded
- AVIR 2012
- CLBR 2023
- Country
- AVIR United States
- CLBR United States
- Employees
- AVIR N/A
- CLBR N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- CLBR
- Sector
- AVIR Health Care
- CLBR
- Exchange
- AVIR Nasdaq
- CLBR Nasdaq
- Market Cap
- AVIR 251.7M
- CLBR 230.6M
- IPO Year
- AVIR 2020
- CLBR 2023
- Fundamental
- Price
- AVIR $3.09
- CLBR $10.75
- Analyst Decision
- AVIR Hold
- CLBR
- Analyst Count
- AVIR 1
- CLBR 0
- Target Price
- AVIR $6.88
- CLBR N/A
- AVG Volume (30 Days)
- AVIR 318.0K
- CLBR 172.4K
- Earning Date
- AVIR 03-03-2025
- CLBR 01-01-0001
- Dividend Yield
- AVIR N/A
- CLBR N/A
- EPS Growth
- AVIR N/A
- CLBR N/A
- EPS
- AVIR N/A
- CLBR N/A
- Revenue
- AVIR N/A
- CLBR N/A
- Revenue This Year
- AVIR N/A
- CLBR N/A
- Revenue Next Year
- AVIR N/A
- CLBR N/A
- P/E Ratio
- AVIR N/A
- CLBR $138.04
- Revenue Growth
- AVIR N/A
- CLBR N/A
- 52 Week Low
- AVIR $2.75
- CLBR $10.15
- 52 Week High
- AVIR $4.60
- CLBR $12.28
- Technical
- Relative Strength Index (RSI)
- AVIR 48.26
- CLBR 37.79
- Support Level
- AVIR $3.04
- CLBR $10.73
- Resistance Level
- AVIR $3.25
- CLBR $11.27
- Average True Range (ATR)
- AVIR 0.13
- CLBR 0.08
- MACD
- AVIR 0.01
- CLBR 0.00
- Stochastic Oscillator
- AVIR 54.29
- CLBR 9.43
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About CLBR Colombier Acquisition Corp. II
Colombier Acquisition Corp II is a blank check company.